Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 5
2012 5
2013 3
2015 3
2016 4
2018 4
2019 6
2020 5
2021 7
2022 5
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
Progress in Understanding and Treating SCN2A-Mediated Disorders.
Sanders SJ, Campbell AJ, Cottrell JR, Moller RS, Wagner FF, Auldridge AL, Bernier RA, Catterall WA, Chung WK, Empfield JR, George AL Jr, Hipp JF, Khwaja O, Kiskinis E, Lal D, Malhotra D, Millichap JJ, Otis TS, Petrou S, Pitt G, Schust LF, Taylor CM, Tjernagel J, Spiro JE, Bender KJ. Sanders SJ, et al. Among authors: hipp jf. Trends Neurosci. 2018 Jul;41(7):442-456. doi: 10.1016/j.tins.2018.03.011. Epub 2018 Apr 23. Trends Neurosci. 2018. PMID: 29691040 Free PMC article. Review.
Clinical Characterization of Epilepsy in Children With Angelman Syndrome.
Cassater D, Bustamante M, Sach-Peltason L, Rotenberg A, Nespeca M, Tan WH, Bird LM, Hipp JF. Cassater D, et al. Among authors: hipp jf. Pediatr Neurol. 2021 Nov;124:42-50. doi: 10.1016/j.pediatrneurol.2021.08.007. Epub 2021 Aug 31. Pediatr Neurol. 2021. PMID: 34536900 Free PMC article. Clinical Trial.
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome.
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group. Goeldner C, et al. Among authors: hipp jf. J Neurodev Disord. 2022 Feb 5;14(1):10. doi: 10.1186/s11689-022-09418-0. J Neurodev Disord. 2022. PMID: 35123401 Free PMC article. Clinical Trial.
Properties of beta oscillations in Dup15q syndrome.
Saravanapandian V, Frohlich J, Hipp JF, Hyde C, Scheffler AW, Golshani P, Cook EH, Reiter LT, Senturk D, Jeste SS. Saravanapandian V, et al. Among authors: hipp jf. J Neurodev Disord. 2020 Aug 13;12(1):22. doi: 10.1186/s11689-020-09326-1. J Neurodev Disord. 2020. PMID: 32791992 Free PMC article.
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities.
Krishnan ML, Berry-Kravis E, Capal JK, Carpenter R, Gringras P, Hipp JF, Miller MT, Mingorance A, Philpot BD, Pletcher MT, Rotenberg A, Tjeertes J, Wang PP, Willgoss T, de Wit MC, Jeste SS. Krishnan ML, et al. Among authors: hipp jf. Nat Rev Drug Discov. 2021 Sep;20(9):653-654. doi: 10.1038/d41573-021-00085-9. Nat Rev Drug Discov. 2021. PMID: 34002058 No abstract available.
Resting state EEG power spectrum and functional connectivity in autism: a cross-sectional analysis.
Garcés P, Baumeister S, Mason L, Chatham CH, Holiga S, Dukart J, Jones EJH, Banaschewski T, Baron-Cohen S, Bölte S, Buitelaar JK, Durston S, Oranje B, Persico AM, Beckmann CF, Bougeron T, Dell'Acqua F, Ecker C, Moessnang C, Charman T, Tillmann J, Murphy DGM, Johnson M, Loth E, Brandeis D, Hipp JF; EU-AIMS LEAP group authorship. Garcés P, et al. Among authors: hipp jf. Mol Autism. 2022 May 18;13(1):22. doi: 10.1186/s13229-022-00500-x. Mol Autism. 2022. PMID: 35585637 Free PMC article.
44 results